Filing Details
- Accession Number:
- 0001209191-19-006009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-30 16:29:51
- Reporting Period:
- 2019-01-28
- Accepted Time:
- 2019-01-30 16:29:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445283 | Proteostasis Therapeutics Inc. | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661335 | Shun Po Lee | C/O Proteostasis Therapeutics, Inc. 80 Guest Street, Suite 500 Boston MA 02135 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-28 | 1,600 | $3.00 | 3,024 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-29 | 712 | $3.00 | 2,312 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Includes 712 shares acquired on June 30, 2018 and 2,312 shares acquired on December 31, 2018, in each case pursuant to PTI's 2016 Employee Stock Purchase Plan.
Billionaire Hedge Funds
